| Patent application number | Description | Published |
|---|
| 20100160464 | Zeolite Supported Cobalt Hybrid Fischer-Tropsch Catalyst - A method for forming a catalyst for synthesis gas conversion comprises impregnating a zeolite extrudate using a solution, for example, a substantially non-aqueous solution, comprising a cobalt salt to provide an impregnated zeolite extrudate and activating the impregnated zeolite extrudate by a reduction-oxidation-reduction cycle. | 06-24-2010 |
| 20100312030 | PROCESS OF SYNTHESIS GAS CONVERSION TO LIQUID FUELS USING SYNTHESIS GAS CONVERSION CATALYST AND NOBLE METAL-PROMOTED ACIDIC ZEOLITE HYDROCRACKING-HYDROISOMERIZATION CATALYST - A process is disclosed for converting a feed comprising synthesis gas to liquid hydrocarbons within a single reactor at essentially common reaction conditions. The synthesis gas contacts a first catalyst bed comprising a synthesis gas conversion catalyst, and a second catalyst bed comprising a mixture of a hydrogenation catalyst and a solid acid catalyst. A Fischer-Tropsch wax is formed over the first catalyst bed and the wax is then hydrocracked and hydroisomerized over the second catalyst bed, resulting in liquid hydrocarbons substantially free of solid wax. | 12-09-2010 |
| 20110118368 | PROCESS OF SYNTHESIS GAS CONVERSION TO LIQUID FUELS USING MIXTURE OF SYNTHESIS GAS CONVERSION CATALYST AND DUAL FUNCTIONALITY CATALYST - A process is disclosed for converting a feed comprising synthesis gas to liquid hydrocarbons within a single reactor at essentially common reaction conditions. The synthesis gas contacts a catalyst bed comprising a mixture of a synthesis gas conversion catalyst on a support containing an acidic component and a dual functionality catalyst including a hydrogenation component and a solid acid component. The hydrocarbons produced are liquid at about 0° C., contain at least 25% by volume C | 05-19-2011 |
| 20110124750 | ZEOLITE SUPPORTED COBALT HYBRID FISCHER-TROPSCH CATALYST - A method for performing synthesis gas conversion is disclosed which comprises contacting synthesis gas with a hybrid Fischer-Tropsch catalyst formed by impregnating a ZSM-12 zeolite extrudate using a solution, for example, a substantially non-aqueous solution, comprising a cobalt salt and activating the impregnated zeolite extrudate by a reduction-oxidation-reduction cycle. The method results in reduced methane yield and increased yield of liquid hydrocarbons substantially free of solid wax. | 05-26-2011 |
| 20110144219 | ZEOLITE SUPPORTED COBALT HYBRID FISCHER-TROPSCH CATALYST - A method for forming a catalyst for synthesis gas conversion comprises impregnating a zeolite extrudate using a solution, for example, a substantially non-aqueous solution, comprising a cobalt salt to provide an impregnated zeolite extrudate and activating the impregnated zeolite extrudate by a reduction-oxidation-reduction cycle. | 06-16-2011 |
| 20110160315 | PROCESS OF SYNTHESIS GAS CONVERSION TO LIQUID HYDROCARBON MIXTURES USING SYNTHESIS GAS CONVERSION CATALYST AND HYDROISOMERIZATION CATALYST - A process is disclosed for converting synthesis gas to a liquid hydrocarbon mixture useful as distillate fuel and/or lube base oil which is substantially free of solid wax. A synthesis gas feed is contacted with a synthesis gas conversion catalyst in an upstream bed and a hydroisomerization catalyst containing a metal promoter and an acidic component in a downstream bed within a single reactor at essentially common reaction conditions. A Fischer-Tropsch wax is formed over the synthesis gas conversion catalyst and said wax is subsequently hydroisomerized over the hydroisomerization catalyst, thereby resulting in a liquid hydrocarbon mixture having a desirable product distribution. | 06-30-2011 |
| Patent application number | Description | Published |
|---|
| 20090220538 | VACCINE FOR STAPHYLOCOCCAL INFECTIONS - The present invention describes method of preparation and use of polypeptide vaccine formulation for prevention and control of Staphylococci mediated infections in human, bovine and other mammals, using recombinant DNA technology. | 09-03-2009 |
| 20100015123 | NOVEL THROMBOLYTIC MOLECULES AND A PROCESS THEREFOR - New thrombolytic protein molecules such as recombinant staphylokinase or streptokinase, urokinase, tissue plasminogen activator and the like, and suitable variants thereof, for targeting to brain tissue or any other tissue by either fusing to, or by synthesizing the candidate thrombolytic molecule(s) with a protein sequence comprising a strong amphipathic alpha helix containing protein transduction domain. Thrombolytic protein molecule(s) so engineered with the protein transduction domain is useful for enhanced uptake of such protein thrombolytic molecule(s) across the cell membranes and tissues including the blood brain barrier and find their use in the treatment of vascular thrombosis including cerebrovascular disorders caused by cerebral thrombosis or cerebral haemorrhage when used a as a therapeutic. The design and processes for cloning, expression, purification and protein transduction of such proteins across cell membranes. | 01-21-2010 |
| 20100173842 | VACCINE FOR STAPHYLOCOCCAL INFECTIONS - The invention relates to a method of preparation and use of a polypeptide vaccine formulation for prevention and control of Staphylococci mediated infections in human, bovine and other mammals, using recombinant DNA technology. | 07-08-2010 |
